Author

C. Midgley

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Antibody boosting and short-term durability following SARS-CoV-2 infections in United States longitudinal cohorts, 2020-2024

To characterize anti-nucleocapsid (anti-N) IgG binding antibody responses following first PCR-confirmed SARS-CoV-2 infections in a highly vaccinated population, we evaluated antibody boosting and durability in a longitudinal cohort in Michigan. Among 113 participants with paired pre- and post-infection serum specimens...

Y. Yang, A. Risukhina, A. Callear et al. · medRxiv · 0 citations

Open access Sep 2026

Longitudinal antibody correlates of SARS-CoV-2 infection in a US household cohort during Omicron waves

Higher levels of binding and functional antibodies were associated with reduced risk of SARS-CoV-2 infections across multiple waves between 2021-2025, and support the use of longitudinal serologic surveillance to inform vaccine evaluation and future booster strategies against evolving SARS-CoV-2 variants.

Yangyupei Yang, A. Callear, Matt Smith et al. · medRxiv · 0 citations

Open access Jul 2026

Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study

It is revealed that higher nucleocapsid-binding and Omicron-specific neutralizing antibodies significantly reduce infection risk, suggesting these markers could guide tailored vaccination strategies and risk assessments in pediatric populations.

K. Hoffman, Grace Marshall, C. Frivold et al. · Nature Communications · 0 citations